SilvaCAQueirozLBFonseca C deB, et al.
Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic. Clinics (Sao Paulo)2020;
75: e1931.
2.
SafadiMAPSilvaCAAD.The challenging and unpredictable spectrum of covid-19 in children and adolescents. Rev Paul Pediatr2020; 39: e2020192.
3.
PereiraMFBLitvinovNFarhatSCL, et al.
Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (Sao Paulo)2020;
75: e2209.
4.
KokerODemirkanFGKayaalpG, et al.
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19. Rheumatol Int2020;
40: 1613–1623.
5.
GianfrancescoMHyrichKLAl-AdelyS, et al.
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis2020;
79: 859–866.
